Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,957 total articles

Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business Update

Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business Update

Syntec Optics Holdings, Inc. (Nasdaq: OPTX), a leading U.S.-based optics and photonics manufacturer serving defense, biomedical, communications, and consumer markets, announced it will host a conference call on April 1, 2026, to discuss its financial results and provide a business update. The company highlighted its growth in light-enabled product …

Plus Therapeutics Announces Reverse Stock Split

Plus Therapeutics Announces Reverse Stock Split

Plus Therapeutics declares a 1-for-25 reverse stock split effective April 2, 2026, to increase its share price and comply with Nasdaq's minimum $1.00 bid price rule. The company's common stock will continue trading on the Nasdaq Capital Market under the symbol PSTV, with proportional adjustments made to outstanding shares, equity awards, and warran…

Cloudastructure Inc. Reaffirms Prior Guidance of  Approximately 270% Year-Over-Year Revenue Growth and More Than $5.0 Million in Recognized Revenue in 2025;  Rescheduling Fiscal Year 2025 Conference Call

Cloudastructure Inc. Reaffirms Prior Guidance of Approximately 270% Year-Over-Year Revenue Growth and More Than $5.0 Million in Recognized Revenue in 2025; Rescheduling Fiscal Year 2025 Conference Call

Cloudastructure, Inc., a leader in AI surveillance and remote guarding, reaffirmed its prior guidance predicting approximately 270% year-over-year revenue growth and over $5 million in recognized revenue for fiscal year 2025. The company also announced it will reschedule its conference call to discuss these financial results due to a scheduling con…

Odysight.ai® Announces Dual Listing on the Tel Aviv Stock Exchange

Odysight.ai® Announces Dual Listing on the Tel Aviv Stock Exchange

Odysight.ai Inc., a US-incorporated AI-based visual sensing solutions provider for predictive maintenance and condition monitoring, has announced approval for dual listing on the Tel Aviv Stock Exchange (TASE). The company's shares will begin trading on TASE under the ticker ODYS on April 9, 2026, in addition to its existing Nasdaq listing. This mo…

Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026

Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026

Tonix Pharmaceuticals announced promising Phase 1 results for TNX-4800, a long-acting monoclonal antibody aimed at preventing Lyme disease with a single dose offering about four months of protection. The company plans to initiate a randomized, double-blind, placebo-controlled Phase 2 field study in the first half of 2027 pending FDA clearance, targ…

GXO Strengthens Its Presence in Switzerland with Opening of Sant’Antonino Site, a Future-Ready Logistics Hub

GXO Strengthens Its Presence in Switzerland with Opening of Sant’Antonino Site, a Future-Ready Logistics Hub

GXO Logistics has opened a new technologically advanced and sustainable logistics hub in Sant’Antonino, Switzerland. The facility enhances the company’s footprint in Continental Europe, featuring cutting-edge automation and a strong ESG focus. The hub’s strategic location bolsters supply chain efficiency between Northern and Southern Europe, suppor…

Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies

Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies

Biomea Fusion has initiated two Phase II clinical trials (COVALENT-211 and COVALENT-212) testing their drug icovamenib in distinct type 2 diabetes populations failing existing standard-of-care treatments. Early studies showed promising and durable glycemic control benefits, prompting advancement to larger, targeted studies with topline data expecte…

Director Declaration

Director Declaration

The Magnum Ice Cream Company N.V. announced that its Chief Financial Officer, Abhijit Bhattacharya, has been appointed as a Non-Executive Director and Chair of Kwality Wall's (India) Limited, a subsidiary listed on Indian stock exchanges. The company confirmed no further disclosures are required under UK listing rules. TMICC is a leading global ice…

Materialise to Transfer RapidFit Business to Its Management Team

Materialise to Transfer RapidFit Business to Its Management Team

Materialise NV announces the transfer of its RapidFit business to its existing management team, allowing RapidFit to operate as an independent company. This move aligns with Materialise’s strategy to focus investments on its strongest growth areas while enabling RapidFit to pursue growth opportunities autonomously. RapidFit specializes in 3D-printe…

Sound Group Inc. Announces Special Cash Dividend

Sound Group Inc. Announces Special Cash Dividend

Sound Group Inc., a Nasdaq-listed global AI-powered audio company, announced a special cash dividend of $0.006 per ordinary share to reward shareholders for the company's solid revenue growth, regained profitability, and successful expansion of its AI-powered audio ecosystem in 2025. The dividend totals approximately $5 million and will be paid in …

Tims China Announces Q4 and Full Year 2025 Results Conference Call

Tims China Announces Q4 and Full Year 2025 Results Conference Call

TH International Limited, the exclusive operator of Tim Hortons coffee shops in mainland China, Hong Kong, and Macau, announced it will release its Q4 and full year 2025 financial results on April 14, 2025, followed by a webcast conference call for investors and media. The company emphasizes its local market relevance and data-driven strategy.

BioAtla Announces Share Consolidation

BioAtla Announces Share Consolidation

BioAtla, Inc., a clinical-stage biotechnology company, announced a 50-for-1 share consolidation effective April 6, 2026, aimed at increasing its stock price to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The consolidation aligns with an approved merger where every fifty shares will convert into one share of common stock. Bi…

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

BriaCell Therapeutics Corp. announced that its majority-owned subsidiary BriaPro Therapeutics Corp. completed the acquisition of an exclusive license to develop and commercialize Soluble CD80 (sCD80), a novel biologic agent for cancer treatment. The license was originally secured from the University of Maryland, Baltimore County, and the transactio…

Datacentrex Announces Closing of $20.17 Million Public Offering

Datacentrex Announces Closing of $20.17 Million Public Offering

Datacentrex, a Nasdaq-listed digital infrastructure company specializing in Scrypt compute assets, closed a $20.17 million public offering by selling common stock and pre-funded warrants at $2.00 per share. The net proceeds will be utilized for working capital and general corporate purposes, supporting the company's operations and strategic initiat…

Aqua Metals Reports 2025 Milestone Advancements, Strategic Progress, and Continued Commercialization Momentum

Aqua Metals Reports 2025 Milestone Advancements, Strategic Progress, and Continued Commercialization Momentum

Aqua Metals reported significant 2025 progress including refinement of commercialization strategy for its AquaRefining™ technology, expansion of product capabilities in lithium, nickel, and mixed hydroxide products, and successful pilot-scale recycling demonstrations. The company strengthened its financial position through capital raises, strategic…